Inducible T cell antigen 4-1BB. Analysis of expression and function
- PMID: 7678621
Inducible T cell antigen 4-1BB. Analysis of expression and function
Abstract
4-1BB is an inducible receptor-like protein expressed in both cytolytic and Th cells. Optimal induction of 4-1BB mRNA in T cells required both PMA and ionomycin stimulation, indicating that protein kinase C activation and increases in intracellular Ca2+ were required for its expression. 4-1BB was categorized as an early activation gene since the protein synthesis inhibitor, cycloheximide, blocked the induction of 4-1BB mRNA. A rat mAb, 53A2, was generated against recombinant soluble 4-1BB and was used to characterize this molecule. 4-1BB is a 30-kDa glycoprotein and appears to exist as both a monomer and a 55-kDa dimer on the cell surface of a T cell clone. The 4-1BB protein may be post-translationally modified since its predicted backbone is 25 kDa. FACS analysis indicated that 4-1BB was inducible and expressed on the cell surface of activated splenic T cells and thymocytes. Cross-linking of 4-1BB on anti-CD3-stimulated T cells with 53A2 resulted in a dramatic enhancement of T cell proliferation. This suggests that 4-1BB may function as an accessory signaling molecule during T cell activation.
Similar articles
-
4-1BB T-cell antigen binds to mature B cells and macrophages, and costimulates anti-mu-primed splenic B cells.Eur J Immunol. 1994 Feb;24(2):367-74. doi: 10.1002/eji.1830240215. Eur J Immunol. 1994. PMID: 8299685
-
Novel T cell antigen 4-1BB associates with the protein tyrosine kinase p56lck1.J Immunol. 1993 Aug 1;151(3):1255-62. J Immunol. 1993. PMID: 8335927
-
Genomic organization and chromosomal localization of the T-cell antigen 4-1BB.J Immunol. 1994 Mar 1;152(5):2256-62. J Immunol. 1994. PMID: 8133039
-
Role of 4-1BB in immune responses.Semin Immunol. 1998 Dec;10(6):481-9. doi: 10.1006/smim.1998.0157. Semin Immunol. 1998. PMID: 9826581 Review.
-
Identification of a functional T-cell population by the use of surface markers: present limitations and new strategies.Ann Immunol (Paris). 1982 Sep-Oct;133D(2):147-53. Ann Immunol (Paris). 1982. PMID: 6819808 Review. No abstract available.
Cited by
-
The nature of activatory and tolerogenic dendritic cell-derived signal II.Front Immunol. 2013 Feb 28;4:53. doi: 10.3389/fimmu.2013.00053. eCollection 2013. Front Immunol. 2013. PMID: 23450201 Free PMC article.
-
The tumour necrosis factor/TNF receptor superfamily: therapeutic targets in autoimmune diseases.Clin Exp Immunol. 2011 May;164(2):145-57. doi: 10.1111/j.1365-2249.2011.04375.x. Epub 2011 Mar 14. Clin Exp Immunol. 2011. PMID: 21401577 Free PMC article.
-
CD137 agonism enhances anti-PD1 induced activation of expanded CD8+ T cell clones in a neoadjuvant pancreatic cancer clinical trial.iScience. 2024 Dec 10;28(1):111569. doi: 10.1016/j.isci.2024.111569. eCollection 2025 Jan 17. iScience. 2024. PMID: 39811671 Free PMC article.
-
Modulation of GITR for cancer immunotherapy.Curr Opin Immunol. 2012 Apr;24(2):217-24. doi: 10.1016/j.coi.2011.12.011. Epub 2012 Jan 12. Curr Opin Immunol. 2012. PMID: 22245556 Free PMC article. Review.
-
4-1BB: A promising target for cancer immunotherapy.Front Oncol. 2022 Sep 14;12:968360. doi: 10.3389/fonc.2022.968360. eCollection 2022. Front Oncol. 2022. PMID: 36185242 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous